CHAPTER 13. Non-coding RNA and Multiple Sclerosis: New Targets for Drug Discovery
Drug DiscoveryEmerging Drugs and Targets for Multiple Sclerosis（2019）
摘要
Non-coding RNA (ncRNA) have been described to take part in several molecular pathways regulating cell functions. Hence, they have been postulated as possible therapeutic targets and mediators in several diseases. Regarding multiple sclerosis, they have been described to be involved in the regulation of the immune response and in remyelination. In this chapter, the role of ncRNA in inflammation and remyelination will be addressed, focusing on their therapeutic potential for multiple sclerosis.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要